In a first-of-its-kind study, a cohort of researchers, led by Kelly E. Anderson, PhD, evaluated the effects of state-level insulin out-of-pocket costs across states and payers and over time. Study results could help inform policies aimed at better delivering cost-capped insulin to patients struggling with insulin affordability.